Cargando…

Temporal Dynamics of High-Density Lipoprotein Proteome in Diet-Controlled Subjects with Type 2 Diabetes

We examined the effect of mild hyperglycemia on high-density lipoprotein (HDL) metabolism and kinetics in diet-controlled subjects with type 2 diabetes (T2D). (2)H(2)O-labeling coupled with mass spectrometry was applied to quantify HDL cholesterol turnover and HDL proteome dynamics in subjects with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kheniser, Karim G., Osme, Abdullah, Kim, Chunki, Ilchenko, Serguei, Kasumov, Takhar, Kashyap, Sangeeta R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226298/
https://www.ncbi.nlm.nih.gov/pubmed/32235466
http://dx.doi.org/10.3390/biom10040520
_version_ 1783534256203497472
author Kheniser, Karim G.
Osme, Abdullah
Kim, Chunki
Ilchenko, Serguei
Kasumov, Takhar
Kashyap, Sangeeta R.
author_facet Kheniser, Karim G.
Osme, Abdullah
Kim, Chunki
Ilchenko, Serguei
Kasumov, Takhar
Kashyap, Sangeeta R.
author_sort Kheniser, Karim G.
collection PubMed
description We examined the effect of mild hyperglycemia on high-density lipoprotein (HDL) metabolism and kinetics in diet-controlled subjects with type 2 diabetes (T2D). (2)H(2)O-labeling coupled with mass spectrometry was applied to quantify HDL cholesterol turnover and HDL proteome dynamics in subjects with T2D (n = 9) and age- and BMI-matched healthy controls (n = 8). The activities of lecithin–cholesterol acyltransferase (LCAT), cholesterol ester transfer protein (CETP), and the proinflammatory index of HDL were quantified. Plasma adiponectin levels were reduced in subjects with T2D, which was directly associated with suppressed ABCA1-dependent cholesterol efflux capacity of HDL. The fractional catabolic rates of HDL cholesterol, apolipoprotein A-II (ApoA-II), ApoJ, ApoA-IV, transthyretin, complement C3, and vitamin D-binding protein (all p < 0.05) were increased in subjects with T2D. Despite increased HDL flux of acute-phase HDL proteins, there was no change in the proinflammatory index of HDL. Although LCAT and CETP activities were not affected in subjects with T2D, LCAT was inversely associated with blood glucose and CETP was inversely associated with plasma adiponectin. The degradation rates of ApoA-II and ApoA-IV were correlated with hemoglobin A(1c). In conclusion, there were in vivo impairments in HDL proteome dynamics and HDL metabolism in diet-controlled patients with T2D.
format Online
Article
Text
id pubmed-7226298
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72262982020-05-18 Temporal Dynamics of High-Density Lipoprotein Proteome in Diet-Controlled Subjects with Type 2 Diabetes Kheniser, Karim G. Osme, Abdullah Kim, Chunki Ilchenko, Serguei Kasumov, Takhar Kashyap, Sangeeta R. Biomolecules Article We examined the effect of mild hyperglycemia on high-density lipoprotein (HDL) metabolism and kinetics in diet-controlled subjects with type 2 diabetes (T2D). (2)H(2)O-labeling coupled with mass spectrometry was applied to quantify HDL cholesterol turnover and HDL proteome dynamics in subjects with T2D (n = 9) and age- and BMI-matched healthy controls (n = 8). The activities of lecithin–cholesterol acyltransferase (LCAT), cholesterol ester transfer protein (CETP), and the proinflammatory index of HDL were quantified. Plasma adiponectin levels were reduced in subjects with T2D, which was directly associated with suppressed ABCA1-dependent cholesterol efflux capacity of HDL. The fractional catabolic rates of HDL cholesterol, apolipoprotein A-II (ApoA-II), ApoJ, ApoA-IV, transthyretin, complement C3, and vitamin D-binding protein (all p < 0.05) were increased in subjects with T2D. Despite increased HDL flux of acute-phase HDL proteins, there was no change in the proinflammatory index of HDL. Although LCAT and CETP activities were not affected in subjects with T2D, LCAT was inversely associated with blood glucose and CETP was inversely associated with plasma adiponectin. The degradation rates of ApoA-II and ApoA-IV were correlated with hemoglobin A(1c). In conclusion, there were in vivo impairments in HDL proteome dynamics and HDL metabolism in diet-controlled patients with T2D. MDPI 2020-03-30 /pmc/articles/PMC7226298/ /pubmed/32235466 http://dx.doi.org/10.3390/biom10040520 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kheniser, Karim G.
Osme, Abdullah
Kim, Chunki
Ilchenko, Serguei
Kasumov, Takhar
Kashyap, Sangeeta R.
Temporal Dynamics of High-Density Lipoprotein Proteome in Diet-Controlled Subjects with Type 2 Diabetes
title Temporal Dynamics of High-Density Lipoprotein Proteome in Diet-Controlled Subjects with Type 2 Diabetes
title_full Temporal Dynamics of High-Density Lipoprotein Proteome in Diet-Controlled Subjects with Type 2 Diabetes
title_fullStr Temporal Dynamics of High-Density Lipoprotein Proteome in Diet-Controlled Subjects with Type 2 Diabetes
title_full_unstemmed Temporal Dynamics of High-Density Lipoprotein Proteome in Diet-Controlled Subjects with Type 2 Diabetes
title_short Temporal Dynamics of High-Density Lipoprotein Proteome in Diet-Controlled Subjects with Type 2 Diabetes
title_sort temporal dynamics of high-density lipoprotein proteome in diet-controlled subjects with type 2 diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226298/
https://www.ncbi.nlm.nih.gov/pubmed/32235466
http://dx.doi.org/10.3390/biom10040520
work_keys_str_mv AT kheniserkarimg temporaldynamicsofhighdensitylipoproteinproteomeindietcontrolledsubjectswithtype2diabetes
AT osmeabdullah temporaldynamicsofhighdensitylipoproteinproteomeindietcontrolledsubjectswithtype2diabetes
AT kimchunki temporaldynamicsofhighdensitylipoproteinproteomeindietcontrolledsubjectswithtype2diabetes
AT ilchenkoserguei temporaldynamicsofhighdensitylipoproteinproteomeindietcontrolledsubjectswithtype2diabetes
AT kasumovtakhar temporaldynamicsofhighdensitylipoproteinproteomeindietcontrolledsubjectswithtype2diabetes
AT kashyapsangeetar temporaldynamicsofhighdensitylipoproteinproteomeindietcontrolledsubjectswithtype2diabetes